BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7946797)

  • 1. Endothelial dysfunction in heart failure and potential for reversal by ACE inhibition.
    Drexler H
    Br Heart J; 1994 Sep; 72(3 Suppl):S11-4. PubMed ID: 7946797
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
    Hornig B; Arakawa N; Drexler H
    Eur Heart J; 1998 Jul; 19 Suppl G():G48-53. PubMed ID: 9717056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure.
    Drexler H; Kurz S; Jeserich M; Münzel T; Hornig B
    Am J Cardiol; 1995 Nov; 76(15):13E-18E. PubMed ID: 7484881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinapril demonstrates improved endothelium-mediated vasodilation in patients with chronic heart failure.
    Compr Ther; 1998 Jan; 24(1):38. PubMed ID: 9452901
    [No Abstract]   [Full Text] [Related]  

  • 5. Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies.
    Morgan K
    Br Heart J; 1994 Sep; 72(3 Suppl):S3-10. PubMed ID: 7946800
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition and endothelin antagonism for endothelial dysfunction in heart failure: mono-or combination therapy.
    Bauersachs J; Fraccarollo D; Schäfer A; Ertl G
    J Cardiovasc Pharmacol; 2002 Oct; 40(4):594-600. PubMed ID: 12352322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial function and dysfunction in heart failure.
    Ferrari R; Bachetti T; Agnoletti L; Comini L; Curello S
    Eur Heart J; 1998 Jul; 19 Suppl G():G41-7. PubMed ID: 9717055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endothelial dysfunction in cardial failure: potential mechanisms].
    Varin R; Mulder P; Richard V; Thuillez C
    Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():29-34. PubMed ID: 9515111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.
    Ferrari R; Guardigli G; Ceconi C
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):331-9. PubMed ID: 20577898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions among ACE, kinins and NO.
    Linz W; Wohlfart P; Schölkens BA; Malinski T; Wiemer G
    Cardiovasc Res; 1999 Aug; 43(3):549-61. PubMed ID: 10690327
    [No Abstract]   [Full Text] [Related]  

  • 11. Endothelial dysfunction and inhibition of converting enzyme.
    Vanhoutte PM
    Eur Heart J; 1998 Sep; 19 Suppl J():J7-15. PubMed ID: 9796835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme gene expression in skeletal muscle in patients with chronic heart failure.
    Schaufelberger M; Drexler H; Schieffer E; Swedberg K
    J Card Fail; 1998 Sep; 4(3):185-91. PubMed ID: 9754589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ACE-inhibition on regional circulation in congestive heart failure.
    Swedberg K
    Acta Med Scand Suppl; 1986; 707():91-3. PubMed ID: 3017058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of angiotensin-converting enzyme (ACE) inhibitors in hypertension and heart failure. Role of plasma versus tissue ACE.
    Dzau VJ
    Drugs; 1990; 39 Suppl 2():11-6. PubMed ID: 2160882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced angiotensin-converting enzyme activity and impaired endothelium-dependent vasodilation in aortae from hypertensive rats: evidence for a causal link.
    Goetz RM; Holtz J
    Clin Sci (Lond); 1999 Aug; 97(2):165-74. PubMed ID: 10409471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymes.
    Ennezat PV; Malendowicz SL; Testa M; Colombo PC; Cohen-Solal A; Evans T; LeJemtel TH
    J Am Coll Cardiol; 2001 Jul; 38(1):194-8. PubMed ID: 11451274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction in heart failure.
    Bauersachs J; Widder JD
    Pharmacol Rep; 2008; 60(1):119-26. PubMed ID: 18276993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inheriting a high aerobic fitness predisposes to skeletal muscle and endothelial dysfunction in chronic heart failure.
    Bowen TS; Eisenkolb S; Werner S; Schwarzer M; Schuler G; Adams V
    Int J Cardiol; 2016 Jan; 203():353-6. PubMed ID: 26529086
    [No Abstract]   [Full Text] [Related]  

  • 20. [Endothelial function in coronary atherosclerosis and heart failure--the role of nitric oxide in regulation of vasomotor tone].
    Andreassen AK; Kirkebøen KA
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4066-9. PubMed ID: 10613099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.